Abstract
Specific protein 1 (SP1) might act as a critical transcription regulator in myocardial infarction (MI), but little evidence about its function in regulating cardiac apoptosis, a major cause of MI development, has been revealed. This study tried to investigate the role of SP1 in MI and its interaction with poly-ADP-ribose polymerase (PARP)-1 by using SP1 inhibitor, mithramycin A (mithA). Primary mouse cardiomyocytes and commercial mouse cardiomyocytes were subjected to mithA treatment under hypoxia conditions, while cell viability, Nix promoter activity, and its expression were detected correspondingly. PARP overexpression and knockdown were conducted, respectively, in mithA-treated and SP1-overexpressing cells. Co-immunoprecipitation was used to verify the interaction between PARP and SP1. For in vivo experiments, mithA administration was performed after the injections of adenovirus for PARP overexpression, and then, MI introduction was carried out. Infarct size and lactate dehydrogenase level were measured to assess MI injury. SP1 inhibitor mithA attenuated hypoxia-induced decrease of cell viability and Nix transcriptional activation, which could be inhibited by PARP overexpression. Knockdown of PARP prevented SP1-induced transcription of Nix and cell viability change, and PARP showed direct interaction with SP1. Furthermore, mithA administration reduced MI injuries, while PARP overexpression could suppress the improvement. The cardioprotective role of SP1 inhibitor mithA was demonstrated here expanding the role of SP1 in MI development involving hypoxia-induced cardiac apoptosis. Moreover, PARP acted as a transcriptional coactivator in Nix transcription involving its interaction with SP1.
Similar content being viewed by others
References
Boisguerin P, Giorgi JM, Barrère-Lemaire S (2013) CPP-conjugated anti-apoptotic peptides as therapeutic tools of ischemia-reperfusion injuries. Curr Pharm Des 19:2970–2978
Brown JS, O'Carrigan B, Jackson SP, Yap TA (2017) Targeting DNA repair in cancer: beyond PARP inhibitors. Cancer Discov 7:20–37
Cheng M, An S, Li J (2017) Identifying key genes associated with acute myocardial infarction. Medicine (Baltimore) 96:e7741
Dai C, Chen X, Li J, Comish P, Kang R, Tang D (2020) Transcription factors in ferroptotic cell death. Cancer Gene Ther 27:645–656
Dorn GW 2nd, Kirshenbaum LA (2008) Cardiac reanimation: targeting cardiomyocyte death by BNIP3 and NIX/BNIP3L. Oncogene 27(Suppl 1):S158–S167
Duverger V, Murphy AM, Sheehan D, England K, Cotter TG, Hayes I, Murphy FJ (2004) The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF). Br J Cancer 90:2025–2031
Gálvez AS, Brunskill EW, Marreez Y, Benner BJ, Regula KM, Kirschenbaum LA, Dorn GW 2nd (2006) Distinct pathways regulate proapoptotic Nix and BNip3 in cardiac stress. J Biol Chem 281:1442–1448
Guo C, Zhao W, Bao XF (2019) LncRNA NNT-AS1 affect progesterone resistance by regulating miR-542-3p/survivin axis in endometrial cancer. Clin Surg Res Commun 3:25–35
Hepp MI, Escobar D, Farkas C, Hermosilla VE, Álvarez C, Amigo R, Gutiérrez JL, Castro AF, Pincheira R (2018) A Trichostatin A (TSA)/Sp1-mediated mechanism for the regulation of SALL2 tumor suppressor in Jurkat T cells. Biochim Biophys Acta Gene Regul Mech 1861:623–636. https://doi.org/10.1016/j.bbagrm.2018.05.002
Hu Y, Zhang C, Zhu H, Wang S, Zhou Y, Zhao J, Xia Y, Li D (2020) Luteolin modulates SERCA2a via Sp1 upregulation to attenuate myocardial ischemia/reperfusion injury in mice. Sci Rep 10:15407
Jaipersad AS, Lip GY, Silverman S, Shantsila E (2014) The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol 63:1–11
Kannan P, Yu Y, Wankhade S, Tainsky MA (1999) PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation. Nucleic Acids Res 27:866–874
Kavurma MM, Bobryshev Y, Khachigian LM (2002) Ets-1 positively regulates Fas ligand transcription via cooperative interactions with Sp1. J Biol Chem 277:36244–36252
Lee Y, Gustafsson AB (2009) Role of apoptosis in cardiovascular disease. Apoptosis 14:536–548
Li R, Geng HH, Xiao J, Qin XT, Wang F, Xing JH, Xia YF, Mao Y, Liang JW, Ji XP (2016) miR-7a/b attenuates post-myocardial infarction remodeling and protects H9c2 cardiomyoblast against hypoxia-induced apoptosis involving Sp1 and PARP-1. Sci Rep 6:29082
Lim M, Wang W, Liang L, Han ZB, Li Z, Geng J, Zhao M, Jia H, Feng J, Wei Z, Song B, Zhang J, Li J, Liu T, Wang F, Li T, Li J, Fang Y, Gao J, Han Z (2018) Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction. Stem Cell Res Ther 9:129
Liu W, Wang G, Yakovlev AG (2002) Identification and functional analysis of the rat caspase-3 gene promoter. J Biol Chem 277:8273–8278
Liu X, Liu T, Hu L, Jiang T, Liu H, Wang Y, Lei Y, Zhu J, Bu Y (2020) Identification and characterization of the promoter of cancer-related gene LOXL2. Exp Cell Res 387:111786
Long Y, Wang L, Li Z (2020) SP1-induced SNHG14 aggravates hypertrophic response in in vitro model of cardiac hypertrophy via up-regulation of PCDH17. J Cell Mol Med 24:7115–7126
Luo H, Liang H, Chen J, Xu Y, Chen Y, Xu L, Yun L, Liu J, Yang H, Liu L, Peng J, Liu Z, Tang L, Chen W, Tang H (2017) Hydroquinone induces TK6 cell growth arrest and apoptosis through PARP-1/p53 regulatory pathway. Environ Toxicol 32:2163–2171
Patel RS, Kamil SH, Bachu R, Adikey A, Ravat V, Kaur M, Tankersley WE, Goyal H (2020) Marijuana use and acute myocardial infarction: a systematic review of published cases in the literature. Trends Cardiovasc Med 30:298–307
Rodrigo R, Fernández-Gajardo R, Gutiérrez R, Matamala JM, Carrasco R, Miranda-Merchak A, Feuerhake W (2013) Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol Disord Drug Targets 12:698–714
Roman MG, Flores LC, Cunningham GM, Cheng C, Dube S, Allen C, Remmen HV, Bai Y, Saunders TL, Ikeno Y (2020) Thioredoxin overexpression in mitochondria showed minimum effects on aging and age-related diseases in male C57BL/6 mice. Aging Pathobiol Ther 2:20–31
Schiewer MJ, Mandigo AC, Gordon N, Huang F, Gaur S, de Leeuw R, Zhao SG, Evans J, Han S, Parsons T, Birbe R, McCue P, McNair C, Chand SN, Cendon-Florez Y, Gallagher P, McCann JJ, Poudel Neupane N, Shafi AA, Dylgjeri E, Brand LJ, Visakorpi T, Raj GV, Lallas CD, Trabulsi EJ, Gomella LG, Dicker AP, Kelly WK, Leiby BE, Knudsen B, Feng FY, Knudsen KE (2018) PARP-1 regulates DNA repair factor availability. EMBO Mol Med 10:e8816
Smit M, Coetzee AR, Lochner A (2020) The pathophysiology of myocardial ischemia and perioperative myocardial infarction. J Cardiothorac Vasc Anesth 34:2501–2512
Song K, Nam YJ, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, Hill JA, Bassel-Duby R, Olson EN (2012) Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485:599–604
Sun T, Dong YH, Du W, Shi CY, Wang K, Tariq MA, Wang JX, Li PF (2017) The role of MicroRNAs in myocardial infarction: from molecular mechanism to clinical application. Int J Mol Sci 18:745
Syed M, Ball JP, Mathis KW, Hall ME, Ryan MJ, Rothenberg ME, Yanes Cardozo LL, Romero DG (2018) MicroRNA-21 ablation exacerbates aldosterone-mediated cardiac injury, remodeling, and dysfunction. Am J Physiol Endocrinol Metab 315:E1154–e1167
Szepes M, Janicsek Z, Benkő Z, Cselenyák A, Kiss L (2013) Pretreatment of therapeutic cells with poly(ADP-ribose) polymerase inhibitor enhances their efficacy in an in vitro model of cell-based therapy in myocardial infarct. Int J Mol Med 31:26–32
Tan NY, Khachigian LM (2009) Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol 29:2483–2488
Tian C, Gao L, Zimmerman MC, Zucker IH (2018) Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure. Am J Phys Heart Circ Phys 314:H928–h939
Tidyman WE, Sehnert AJ, Huq A, Agard J, Deegan F, Stainier DY, Ordahl CP (2003) In vivo regulation of the chicken cardiac troponin T gene promoter in zebrafish embryos. Dev Dyn 227:484–496
Wang L, Yang J, Wang H et al (2020) Highly expressed ribosomal protein L34 predicts poor prognosis in acute myeloid leukemia and could be a potential therapy target. Aging Pathobiol Ther 2:32–37
Wei C, Zhang W, Zhou Q, Zhao C, Du Y, Yan Q, Li Z, Miao J (2016) Mithramycin A alleviates cognitive deficits and reduces neuropathology in a transgenic mouse model of Alzheimer's disease. Neurochem Res 41:1924–1938
Wu X, Dong Z, Wang CJ, Barlow LJ, Fako V, Serrano MA, Zou Y, Liu JY, Zhang JT (2016) FASN regulates cellular response to genotoxic treatments by increasing PARP-1 expression and DNA repair activity via NF-κB and SP1. Proc Natl Acad Sci U S A 113:E6965–e6973
Zaniolo K, Rufiange A, Leclerc S, Desnoyers S, Guérin SL (2005) Regulation of the poly(ADP-ribose) polymerase-1 gene expression by the transcription factors Sp1 and Sp3 is under the influence of cell density in primary cultured cells. Biochem J 389:423–433
Zaniolo K, Desnoyers S, Leclerc S, Guérin SL (2007) Regulation of poly(ADP-ribose) polymerase-1 (PARP-1) gene expression through the post-translational modification of Sp1: a nuclear target protein of PARP-1. BMC Mol Biol 8:96
Zhang G, Shi H, Wang L, Zhou M, Wang Z, Liu X, Cheng L, Li W, Li X (2015) MicroRNA and transcription factor mediated regulatory network analysis reveals critical regulators and regulatory modules in myocardial infarction. PLoS One 10:e0135339
Zhang J, Ney PA (2009) Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ 16:939–946
Zhang L, Wang YM (2019) Expression and function of lncRNA ANRIL in a mouse model of acute myocardial infarction combined with type 2 diabetes mellitus. J Chin Med Assoc 82:685–692
Zhang X, Li R, Qin X, Wang L, Xiao J, Song Y, Sheng X, Guo M, Ji X (2018) Sp1 plays an important role in vascular calcification both in vivo and in vitro. J Am Heart Assoc 7:E007555
Zhao N, Yu H, Yu H, Sun M, Zhang Y, Xu M, Gao W (2013) MiRNA-711-SP1-collagen-I pathway is involved in the anti-fibrotic effect of pioglitazone in myocardial infarction. Sci China Life Sci 56:431–439
Zhou S, Sun W, Zhang Z, Zheng Y (2014) The role of Nrf2-mediated pathway in cardiac remodeling and heart failure. Oxidative Med Cell Longev 2014:260429
Funding
This study was supported by the Nantong Applied Research Project (Grant No. MS12018039).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Editor: Tetsuji Okamoto
Rights and permissions
About this article
Cite this article
Geng, H., Su, Y., Huang, R. et al. Specific protein 1 inhibitor mithramycin A protects cardiomyocytes from myocardial infarction via interacting with PARP. In Vitro Cell.Dev.Biol.-Animal 57, 315–323 (2021). https://doi.org/10.1007/s11626-021-00543-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-021-00543-z